Annora Pharma Private Limited — FDA Class II (D-0626-2026)

Annora Pharma Private Limited is recalling a human prescription drug due to contamination with a foreign tablet. The recall involves 31,392 bottles, each containing 60 tablets. This action is classified as a Class I recall, indicating a serious risk to health.

• •Annora Pharma is recalling a human prescription drug.
• •The recall is due to a foreign tablet found in bottles.
• •31,392 bottles are affected, each with 60 tablets.
• •Customers should check their medicine cabinets for these products.
• •Class I recalls indicate serious health risks.

Patients who have these medications could be at risk if they take the wrong tablets. They should return the products to the pharmacy.